nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftibuten—SLC15A1—Lisinopril—systemic scleroderma	0.443	0.572	CbGbCtD
Ceftibuten—SLC15A1—Captopril—systemic scleroderma	0.331	0.428	CbGbCtD
Ceftibuten—Dyspepsia—Mometasone—systemic scleroderma	0.000656	0.00291	CcSEcCtD
Ceftibuten—Anaphylactic shock—Captopril—systemic scleroderma	0.000654	0.0029	CcSEcCtD
Ceftibuten—Flatulence—Leflunomide—systemic scleroderma	0.000651	0.00289	CcSEcCtD
Ceftibuten—Chills—Mycophenolic acid—systemic scleroderma	0.00065	0.00288	CcSEcCtD
Ceftibuten—Decreased appetite—Mometasone—systemic scleroderma	0.000648	0.00287	CcSEcCtD
Ceftibuten—Dysgeusia—Leflunomide—systemic scleroderma	0.000647	0.00287	CcSEcCtD
Ceftibuten—Vaginal inflammation—Methotrexate—systemic scleroderma	0.000645	0.00286	CcSEcCtD
Ceftibuten—Fatigue—Mometasone—systemic scleroderma	0.000642	0.00285	CcSEcCtD
Ceftibuten—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000636	0.00282	CcSEcCtD
Ceftibuten—Melaena—Methotrexate—systemic scleroderma	0.00063	0.00279	CcSEcCtD
Ceftibuten—Renal failure—Mycophenolate mofetil—systemic scleroderma	0.000626	0.00277	CcSEcCtD
Ceftibuten—Anorexia—Captopril—systemic scleroderma	0.000624	0.00276	CcSEcCtD
Ceftibuten—Flatulence—Mycophenolic acid—systemic scleroderma	0.000621	0.00275	CcSEcCtD
Ceftibuten—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000621	0.00275	CcSEcCtD
Ceftibuten—Asthenia—Pentoxifylline—systemic scleroderma	0.00062	0.00274	CcSEcCtD
Ceftibuten—Erythema multiforme—Lisinopril—systemic scleroderma	0.000617	0.00273	CcSEcCtD
Ceftibuten—Pruritus—Pentoxifylline—systemic scleroderma	0.000611	0.00271	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000609	0.0027	CcSEcCtD
Ceftibuten—Vaginal infection—Methotrexate—systemic scleroderma	0.000609	0.0027	CcSEcCtD
Ceftibuten—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000607	0.00269	CcSEcCtD
Ceftibuten—Aplastic anaemia—Methotrexate—systemic scleroderma	0.000605	0.00268	CcSEcCtD
Ceftibuten—Agranulocytosis—Mycophenolate mofetil—systemic scleroderma	0.000594	0.00263	CcSEcCtD
Ceftibuten—Insomnia—Captopril—systemic scleroderma	0.000592	0.00262	CcSEcCtD
Ceftibuten—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000591	0.00262	CcSEcCtD
Ceftibuten—Abdominal pain—Mometasone—systemic scleroderma	0.000589	0.00261	CcSEcCtD
Ceftibuten—Body temperature increased—Mometasone—systemic scleroderma	0.000589	0.00261	CcSEcCtD
Ceftibuten—Paraesthesia—Captopril—systemic scleroderma	0.000588	0.0026	CcSEcCtD
Ceftibuten—Chills—Lisinopril—systemic scleroderma	0.000585	0.00259	CcSEcCtD
Ceftibuten—Dyspnoea—Captopril—systemic scleroderma	0.000583	0.00258	CcSEcCtD
Ceftibuten—Somnolence—Captopril—systemic scleroderma	0.000582	0.00258	CcSEcCtD
Ceftibuten—Agitation—Mycophenolic acid—systemic scleroderma	0.000579	0.00257	CcSEcCtD
Ceftibuten—Dyspepsia—Captopril—systemic scleroderma	0.000576	0.00255	CcSEcCtD
Ceftibuten—Haemoglobin—Mycophenolate mofetil—systemic scleroderma	0.000574	0.00254	CcSEcCtD
Ceftibuten—Haemorrhage—Mycophenolate mofetil—systemic scleroderma	0.000572	0.00253	CcSEcCtD
Ceftibuten—Dizziness—Pentoxifylline—systemic scleroderma	0.000571	0.00253	CcSEcCtD
Ceftibuten—Decreased appetite—Captopril—systemic scleroderma	0.000569	0.00252	CcSEcCtD
Ceftibuten—Fatigue—Captopril—systemic scleroderma	0.000564	0.0025	CcSEcCtD
Ceftibuten—Constipation—Captopril—systemic scleroderma	0.00056	0.00248	CcSEcCtD
Ceftibuten—Flatulence—Lisinopril—systemic scleroderma	0.00056	0.00248	CcSEcCtD
Ceftibuten—Dysgeusia—Lisinopril—systemic scleroderma	0.000556	0.00246	CcSEcCtD
Ceftibuten—Dry mouth—Leflunomide—systemic scleroderma	0.00055	0.00244	CcSEcCtD
Ceftibuten—Vomiting—Pentoxifylline—systemic scleroderma	0.000549	0.00243	CcSEcCtD
Ceftibuten—Psychotic disorder—Prednisone—systemic scleroderma	0.000547	0.00242	CcSEcCtD
Ceftibuten—Convulsion—Mycophenolic acid—systemic scleroderma	0.000546	0.00242	CcSEcCtD
Ceftibuten—Rash—Pentoxifylline—systemic scleroderma	0.000544	0.00241	CcSEcCtD
Ceftibuten—Dermatitis—Pentoxifylline—systemic scleroderma	0.000544	0.00241	CcSEcCtD
Ceftibuten—Headache—Pentoxifylline—systemic scleroderma	0.000541	0.0024	CcSEcCtD
Ceftibuten—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000539	0.00239	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Captopril—systemic scleroderma	0.000535	0.00237	CcSEcCtD
Ceftibuten—Asthenia—Mometasone—systemic scleroderma	0.000535	0.00237	CcSEcCtD
Ceftibuten—Irritability—Prednisone—systemic scleroderma	0.000535	0.00237	CcSEcCtD
Ceftibuten—Pruritus—Mometasone—systemic scleroderma	0.000527	0.00234	CcSEcCtD
Ceftibuten—Dry mouth—Mycophenolic acid—systemic scleroderma	0.000525	0.00233	CcSEcCtD
Ceftibuten—Abdominal pain—Captopril—systemic scleroderma	0.000517	0.00229	CcSEcCtD
Ceftibuten—Body temperature increased—Captopril—systemic scleroderma	0.000517	0.00229	CcSEcCtD
Ceftibuten—Anorexia—Leflunomide—systemic scleroderma	0.000514	0.00228	CcSEcCtD
Ceftibuten—Nausea—Pentoxifylline—systemic scleroderma	0.000513	0.00227	CcSEcCtD
Ceftibuten—Chills—Mycophenolate mofetil—systemic scleroderma	0.000513	0.00227	CcSEcCtD
Ceftibuten—Diarrhoea—Mometasone—systemic scleroderma	0.00051	0.00226	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000493	0.00218	CcSEcCtD
Ceftibuten—Anorexia—Mycophenolic acid—systemic scleroderma	0.00049	0.00217	CcSEcCtD
Ceftibuten—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.00049	0.00217	CcSEcCtD
Ceftibuten—Insomnia—Leflunomide—systemic scleroderma	0.000488	0.00216	CcSEcCtD
Ceftibuten—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.000487	0.00216	CcSEcCtD
Ceftibuten—Paraesthesia—Leflunomide—systemic scleroderma	0.000484	0.00215	CcSEcCtD
Ceftibuten—Dyspnoea—Leflunomide—systemic scleroderma	0.000481	0.00213	CcSEcCtD
Ceftibuten—Dyspepsia—Leflunomide—systemic scleroderma	0.000475	0.0021	CcSEcCtD
Ceftibuten—Vomiting—Mometasone—systemic scleroderma	0.000474	0.0021	CcSEcCtD
Ceftibuten—Dry mouth—Lisinopril—systemic scleroderma	0.000473	0.00209	CcSEcCtD
Ceftibuten—Rash—Mometasone—systemic scleroderma	0.00047	0.00208	CcSEcCtD
Ceftibuten—Asthenia—Captopril—systemic scleroderma	0.00047	0.00208	CcSEcCtD
Ceftibuten—Dermatitis—Mometasone—systemic scleroderma	0.000469	0.00208	CcSEcCtD
Ceftibuten—Decreased appetite—Leflunomide—systemic scleroderma	0.000469	0.00208	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000467	0.00207	CcSEcCtD
Ceftibuten—Headache—Mometasone—systemic scleroderma	0.000467	0.00207	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000466	0.00206	CcSEcCtD
Ceftibuten—Insomnia—Mycophenolic acid—systemic scleroderma	0.000465	0.00206	CcSEcCtD
Ceftibuten—Fatigue—Leflunomide—systemic scleroderma	0.000465	0.00206	CcSEcCtD
Ceftibuten—Anaphylactic shock—Lisinopril—systemic scleroderma	0.000463	0.00205	CcSEcCtD
Ceftibuten—Pruritus—Captopril—systemic scleroderma	0.000463	0.00205	CcSEcCtD
Ceftibuten—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000462	0.00205	CcSEcCtD
Ceftibuten—Constipation—Leflunomide—systemic scleroderma	0.000461	0.00204	CcSEcCtD
Ceftibuten—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000459	0.00203	CcSEcCtD
Ceftibuten—Somnolence—Mycophenolic acid—systemic scleroderma	0.000457	0.00203	CcSEcCtD
Ceftibuten—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000457	0.00203	CcSEcCtD
Ceftibuten—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000453	0.00201	CcSEcCtD
Ceftibuten—Neutropenia—Prednisone—systemic scleroderma	0.000453	0.00201	CcSEcCtD
Ceftibuten—Abdominal pain—Azathioprine—systemic scleroderma	0.000452	0.002	CcSEcCtD
Ceftibuten—Body temperature increased—Azathioprine—systemic scleroderma	0.000452	0.002	CcSEcCtD
Ceftibuten—Diarrhoea—Captopril—systemic scleroderma	0.000448	0.00198	CcSEcCtD
Ceftibuten—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000447	0.00198	CcSEcCtD
Ceftibuten—Irritability—Methotrexate—systemic scleroderma	0.000447	0.00198	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000444	0.00197	CcSEcCtD
Ceftibuten—Fatigue—Mycophenolic acid—systemic scleroderma	0.000444	0.00197	CcSEcCtD
Ceftibuten—Nausea—Mometasone—systemic scleroderma	0.000443	0.00196	CcSEcCtD
Ceftibuten—Anorexia—Lisinopril—systemic scleroderma	0.000442	0.00196	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000441	0.00195	CcSEcCtD
Ceftibuten—Constipation—Mycophenolic acid—systemic scleroderma	0.00044	0.00195	CcSEcCtD
Ceftibuten—Dizziness—Captopril—systemic scleroderma	0.000433	0.00192	CcSEcCtD
Ceftibuten—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00191	CcSEcCtD
Ceftibuten—Urticaria—Leflunomide—systemic scleroderma	0.000428	0.0019	CcSEcCtD
Ceftibuten—Abdominal pain—Leflunomide—systemic scleroderma	0.000426	0.00189	CcSEcCtD
Ceftibuten—Body temperature increased—Leflunomide—systemic scleroderma	0.000426	0.00189	CcSEcCtD
Ceftibuten—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000421	0.00187	CcSEcCtD
Ceftibuten—Hypersensitivity—Azathioprine—systemic scleroderma	0.000421	0.00186	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000421	0.00186	CcSEcCtD
Ceftibuten—Insomnia—Lisinopril—systemic scleroderma	0.000419	0.00186	CcSEcCtD
Ceftibuten—Paraesthesia—Lisinopril—systemic scleroderma	0.000416	0.00184	CcSEcCtD
Ceftibuten—Vomiting—Captopril—systemic scleroderma	0.000416	0.00184	CcSEcCtD
Ceftibuten—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000414	0.00184	CcSEcCtD
Ceftibuten—Dyspnoea—Lisinopril—systemic scleroderma	0.000413	0.00183	CcSEcCtD
Ceftibuten—Rash—Captopril—systemic scleroderma	0.000413	0.00183	CcSEcCtD
Ceftibuten—Dermatitis—Captopril—systemic scleroderma	0.000412	0.00183	CcSEcCtD
Ceftibuten—Somnolence—Lisinopril—systemic scleroderma	0.000412	0.00183	CcSEcCtD
Ceftibuten—Headache—Captopril—systemic scleroderma	0.00041	0.00182	CcSEcCtD
Ceftibuten—Dyspepsia—Lisinopril—systemic scleroderma	0.000408	0.00181	CcSEcCtD
Ceftibuten—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000407	0.0018	CcSEcCtD
Ceftibuten—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000407	0.0018	CcSEcCtD
Ceftibuten—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000406	0.0018	CcSEcCtD
Ceftibuten—Decreased appetite—Lisinopril—systemic scleroderma	0.000403	0.00178	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.0004	0.00177	CcSEcCtD
Ceftibuten—Fatigue—Lisinopril—systemic scleroderma	0.0004	0.00177	CcSEcCtD
Ceftibuten—Hypersensitivity—Leflunomide—systemic scleroderma	0.000397	0.00176	CcSEcCtD
Ceftibuten—Constipation—Lisinopril—systemic scleroderma	0.000396	0.00176	CcSEcCtD
Ceftibuten—Diarrhoea—Azathioprine—systemic scleroderma	0.000391	0.00173	CcSEcCtD
Ceftibuten—Haemoglobin—Prednisone—systemic scleroderma	0.000389	0.00173	CcSEcCtD
Ceftibuten—Nausea—Captopril—systemic scleroderma	0.000389	0.00172	CcSEcCtD
Ceftibuten—Haemorrhage—Prednisone—systemic scleroderma	0.000387	0.00172	CcSEcCtD
Ceftibuten—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000387	0.00171	CcSEcCtD
Ceftibuten—Asthenia—Leflunomide—systemic scleroderma	0.000387	0.00171	CcSEcCtD
Ceftibuten—Pancytopenia—Methotrexate—systemic scleroderma	0.000384	0.0017	CcSEcCtD
Ceftibuten—Pruritus—Leflunomide—systemic scleroderma	0.000382	0.00169	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000379	0.00168	CcSEcCtD
Ceftibuten—Dysuria—Methotrexate—systemic scleroderma	0.000378	0.00168	CcSEcCtD
Ceftibuten—Neutropenia—Methotrexate—systemic scleroderma	0.000378	0.00168	CcSEcCtD
Ceftibuten—Dizziness—Azathioprine—systemic scleroderma	0.000378	0.00167	CcSEcCtD
Ceftibuten—Asthenia—Mycophenolic acid—systemic scleroderma	0.000369	0.00164	CcSEcCtD
Ceftibuten—Diarrhoea—Leflunomide—systemic scleroderma	0.000369	0.00163	CcSEcCtD
Ceftibuten—Urticaria—Lisinopril—systemic scleroderma	0.000368	0.00163	CcSEcCtD
Ceftibuten—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000367	0.00163	CcSEcCtD
Ceftibuten—Abdominal pain—Lisinopril—systemic scleroderma	0.000366	0.00162	CcSEcCtD
Ceftibuten—Body temperature increased—Lisinopril—systemic scleroderma	0.000366	0.00162	CcSEcCtD
Ceftibuten—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000365	0.00162	CcSEcCtD
Ceftibuten—Pruritus—Mycophenolic acid—systemic scleroderma	0.000364	0.00161	CcSEcCtD
Ceftibuten—Vomiting—Azathioprine—systemic scleroderma	0.000363	0.00161	CcSEcCtD
Ceftibuten—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000362	0.0016	CcSEcCtD
Ceftibuten—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000361	0.0016	CcSEcCtD
Ceftibuten—Rash—Azathioprine—systemic scleroderma	0.00036	0.0016	CcSEcCtD
Ceftibuten—Dermatitis—Azathioprine—systemic scleroderma	0.00036	0.00159	CcSEcCtD
Ceftibuten—Headache—Azathioprine—systemic scleroderma	0.000358	0.00159	CcSEcCtD
Ceftibuten—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000358	0.00158	CcSEcCtD
Ceftibuten—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000357	0.00158	CcSEcCtD
Ceftibuten—Dizziness—Leflunomide—systemic scleroderma	0.000357	0.00158	CcSEcCtD
Ceftibuten—Renal failure—Methotrexate—systemic scleroderma	0.000355	0.00157	CcSEcCtD
Ceftibuten—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000353	0.00156	CcSEcCtD
Ceftibuten—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000352	0.00156	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000351	0.00155	CcSEcCtD
Ceftibuten—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000347	0.00154	CcSEcCtD
Ceftibuten—Haematuria—Methotrexate—systemic scleroderma	0.000344	0.00152	CcSEcCtD
Ceftibuten—Vomiting—Leflunomide—systemic scleroderma	0.000343	0.00152	CcSEcCtD
Ceftibuten—Hypersensitivity—Lisinopril—systemic scleroderma	0.000341	0.00151	CcSEcCtD
Ceftibuten—Dizziness—Mycophenolic acid—systemic scleroderma	0.00034	0.00151	CcSEcCtD
Ceftibuten—Rash—Leflunomide—systemic scleroderma	0.00034	0.00151	CcSEcCtD
Ceftibuten—Dermatitis—Leflunomide—systemic scleroderma	0.00034	0.00151	CcSEcCtD
Ceftibuten—Nausea—Azathioprine—systemic scleroderma	0.000339	0.0015	CcSEcCtD
Ceftibuten—Headache—Leflunomide—systemic scleroderma	0.000338	0.0015	CcSEcCtD
Ceftibuten—Agranulocytosis—Methotrexate—systemic scleroderma	0.000337	0.00149	CcSEcCtD
Ceftibuten—Asthenia—Lisinopril—systemic scleroderma	0.000333	0.00147	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000332	0.00147	CcSEcCtD
Ceftibuten—Pruritus—Lisinopril—systemic scleroderma	0.000328	0.00145	CcSEcCtD
Ceftibuten—Vomiting—Mycophenolic acid—systemic scleroderma	0.000327	0.00145	CcSEcCtD
Ceftibuten—Haemoglobin—Methotrexate—systemic scleroderma	0.000325	0.00144	CcSEcCtD
Ceftibuten—Rash—Mycophenolic acid—systemic scleroderma	0.000324	0.00144	CcSEcCtD
Ceftibuten—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000324	0.00144	CcSEcCtD
Ceftibuten—Haemorrhage—Methotrexate—systemic scleroderma	0.000324	0.00143	CcSEcCtD
Ceftibuten—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000323	0.00143	CcSEcCtD
Ceftibuten—Headache—Mycophenolic acid—systemic scleroderma	0.000322	0.00143	CcSEcCtD
Ceftibuten—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00142	CcSEcCtD
Ceftibuten—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000321	0.00142	CcSEcCtD
Ceftibuten—Nausea—Leflunomide—systemic scleroderma	0.00032	0.00142	CcSEcCtD
Ceftibuten—Diarrhoea—Lisinopril—systemic scleroderma	0.000317	0.0014	CcSEcCtD
Ceftibuten—Agitation—Prednisone—systemic scleroderma	0.00031	0.00137	CcSEcCtD
Ceftibuten—Dizziness—Lisinopril—systemic scleroderma	0.000306	0.00136	CcSEcCtD
Ceftibuten—Erythema multiforme—Methotrexate—systemic scleroderma	0.000306	0.00136	CcSEcCtD
Ceftibuten—Nausea—Mycophenolic acid—systemic scleroderma	0.000306	0.00135	CcSEcCtD
Ceftibuten—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000299	0.00133	CcSEcCtD
Ceftibuten—Vomiting—Lisinopril—systemic scleroderma	0.000295	0.00131	CcSEcCtD
Ceftibuten—Rash—Lisinopril—systemic scleroderma	0.000292	0.00129	CcSEcCtD
Ceftibuten—Convulsion—Prednisone—systemic scleroderma	0.000292	0.00129	CcSEcCtD
Ceftibuten—Dermatitis—Lisinopril—systemic scleroderma	0.000292	0.00129	CcSEcCtD
Ceftibuten—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000291	0.00129	CcSEcCtD
Ceftibuten—Chills—Methotrexate—systemic scleroderma	0.000291	0.00129	CcSEcCtD
Ceftibuten—Headache—Lisinopril—systemic scleroderma	0.00029	0.00129	CcSEcCtD
Ceftibuten—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00127	CcSEcCtD
Ceftibuten—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000278	0.00123	CcSEcCtD
Ceftibuten—Dysgeusia—Methotrexate—systemic scleroderma	0.000276	0.00122	CcSEcCtD
Ceftibuten—Nausea—Lisinopril—systemic scleroderma	0.000275	0.00122	CcSEcCtD
Ceftibuten—Anaphylactic shock—Prednisone—systemic scleroderma	0.000275	0.00122	CcSEcCtD
Ceftibuten—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000269	0.00119	CcSEcCtD
Ceftibuten—Anorexia—Prednisone—systemic scleroderma	0.000262	0.00116	CcSEcCtD
Ceftibuten—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000258	0.00114	CcSEcCtD
Ceftibuten—Rash—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00113	CcSEcCtD
Ceftibuten—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000256	0.00113	CcSEcCtD
Ceftibuten—Headache—Mycophenolate mofetil—systemic scleroderma	0.000254	0.00113	CcSEcCtD
Ceftibuten—Insomnia—Prednisone—systemic scleroderma	0.000249	0.0011	CcSEcCtD
Ceftibuten—Paraesthesia—Prednisone—systemic scleroderma	0.000247	0.00109	CcSEcCtD
Ceftibuten—Convulsion—Methotrexate—systemic scleroderma	0.000244	0.00108	CcSEcCtD
Ceftibuten—Dyspepsia—Prednisone—systemic scleroderma	0.000242	0.00107	CcSEcCtD
Ceftibuten—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00107	CcSEcCtD
Ceftibuten—Decreased appetite—Prednisone—systemic scleroderma	0.000239	0.00106	CcSEcCtD
Ceftibuten—Fatigue—Prednisone—systemic scleroderma	0.000237	0.00105	CcSEcCtD
Ceftibuten—Constipation—Prednisone—systemic scleroderma	0.000235	0.00104	CcSEcCtD
Ceftibuten—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00023	0.00102	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000225	0.000997	CcSEcCtD
Ceftibuten—Anorexia—Methotrexate—systemic scleroderma	0.000219	0.000971	CcSEcCtD
Ceftibuten—Urticaria—Prednisone—systemic scleroderma	0.000219	0.000969	CcSEcCtD
Ceftibuten—Body temperature increased—Prednisone—systemic scleroderma	0.000218	0.000964	CcSEcCtD
Ceftibuten—Abdominal pain—Prednisone—systemic scleroderma	0.000218	0.000964	CcSEcCtD
Ceftibuten—Insomnia—Methotrexate—systemic scleroderma	0.000208	0.000922	CcSEcCtD
Ceftibuten—Paraesthesia—Methotrexate—systemic scleroderma	0.000207	0.000915	CcSEcCtD
Ceftibuten—Dyspnoea—Methotrexate—systemic scleroderma	0.000205	0.000909	CcSEcCtD
Ceftibuten—Somnolence—Methotrexate—systemic scleroderma	0.000205	0.000906	CcSEcCtD
Ceftibuten—Hypersensitivity—Prednisone—systemic scleroderma	0.000203	0.000898	CcSEcCtD
Ceftibuten—Dyspepsia—Methotrexate—systemic scleroderma	0.000202	0.000897	CcSEcCtD
Ceftibuten—Decreased appetite—Methotrexate—systemic scleroderma	0.0002	0.000886	CcSEcCtD
Ceftibuten—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000199	0.00088	CcSEcCtD
Ceftibuten—Fatigue—Methotrexate—systemic scleroderma	0.000198	0.000879	CcSEcCtD
Ceftibuten—Asthenia—Prednisone—systemic scleroderma	0.000197	0.000875	CcSEcCtD
Ceftibuten—Pruritus—Prednisone—systemic scleroderma	0.000195	0.000863	CcSEcCtD
Ceftibuten—Diarrhoea—Prednisone—systemic scleroderma	0.000188	0.000834	CcSEcCtD
Ceftibuten—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000188	0.000833	CcSEcCtD
Ceftibuten—Urticaria—Methotrexate—systemic scleroderma	0.000183	0.00081	CcSEcCtD
Ceftibuten—Dizziness—Prednisone—systemic scleroderma	0.000182	0.000806	CcSEcCtD
Ceftibuten—Abdominal pain—Methotrexate—systemic scleroderma	0.000182	0.000806	CcSEcCtD
Ceftibuten—Body temperature increased—Methotrexate—systemic scleroderma	0.000182	0.000806	CcSEcCtD
Ceftibuten—Vomiting—Prednisone—systemic scleroderma	0.000175	0.000775	CcSEcCtD
Ceftibuten—Rash—Prednisone—systemic scleroderma	0.000174	0.000769	CcSEcCtD
Ceftibuten—Dermatitis—Prednisone—systemic scleroderma	0.000173	0.000768	CcSEcCtD
Ceftibuten—Headache—Prednisone—systemic scleroderma	0.000172	0.000764	CcSEcCtD
Ceftibuten—Hypersensitivity—Methotrexate—systemic scleroderma	0.000169	0.000751	CcSEcCtD
Ceftibuten—Asthenia—Methotrexate—systemic scleroderma	0.000165	0.000731	CcSEcCtD
Ceftibuten—Nausea—Prednisone—systemic scleroderma	0.000163	0.000724	CcSEcCtD
Ceftibuten—Pruritus—Methotrexate—systemic scleroderma	0.000163	0.000721	CcSEcCtD
Ceftibuten—Diarrhoea—Methotrexate—systemic scleroderma	0.000157	0.000697	CcSEcCtD
Ceftibuten—Dizziness—Methotrexate—systemic scleroderma	0.000152	0.000674	CcSEcCtD
Ceftibuten—Vomiting—Methotrexate—systemic scleroderma	0.000146	0.000648	CcSEcCtD
Ceftibuten—Rash—Methotrexate—systemic scleroderma	0.000145	0.000643	CcSEcCtD
Ceftibuten—Dermatitis—Methotrexate—systemic scleroderma	0.000145	0.000642	CcSEcCtD
Ceftibuten—Headache—Methotrexate—systemic scleroderma	0.000144	0.000638	CcSEcCtD
Ceftibuten—Nausea—Methotrexate—systemic scleroderma	0.000137	0.000605	CcSEcCtD
